Mast cells in the autonomic nervous system and potential role in disorders with dysautonomia and neuroinflammation

被引:16
|
作者
Theoharides, Theoharis C. [1 ,2 ,3 ]
Twahir, Assma [1 ]
Kempuraj, Duraisamy [1 ]
机构
[1] Nova Southeastern Univ, Dr Kiran C Patel Coll Osteopath Med, Inst Neuroimmune Med, Ft Lauderdale, FL USA
[2] Tufts Univ, Sch Med, Dept Immunol, Lab Mol Immunopharmacol & Drug Discovery, Boston, MA USA
[3] Nova Southeastern Univ, Inst Neuro Immune Med, 3400 Gulf Bay Blvd,Room 3748, Clearwater, FL 33759 USA
关键词
AUTISM SPECTRUM DISORDERS; CHRONIC-FATIGUE-SYNDROME; CORTICOTROPIN-RELEASING HORMONE; BLOOD-BRAIN-BARRIER; POSTURAL TACHYCARDIA SYNDROME; PITUITARY-ADRENOCORTICAL AXIS; MTOR SIGNALING PATHWAY; SUBSTANCE-P; SYNDROME/MYALGIC ENCEPHALOMYELITIS; HISTAMINE-SECRETION;
D O I
10.1016/j.anai.2023.10.032
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Mast cells (MC) are ubiquitous in the body, and they are critical for not only in allergic diseases but also in immunity and in flammation, including having potential involvement in the pathophysiology of dysautonomias and neuroin flammatory disorders. MC are located perivascularly close to nerve endings and sites such as the carotid bodies, heart, hypothalamus, the pineal gland, and the adrenal gland that would allow them not only to regulate but also to be affected by the autonomic nervous system (ANS). MC are stimulated not only by allergens but also many other triggers including some from the ANS that can affect MC release of neurosensitizing, proin flamma- tory, and vasoactive mediators. Hence, MC may be able to regulate homeostatic functions that seem to be dysfunctional in many conditions, such as postural orthostatic tachycardia syndrome, autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, and Long-COVID syndrome. The evidence indicates that there is a possible association between these conditions and diseases associated with MC activation. There is no effective treatment for any form of these conditions other than minimizing symptoms. Given the many ways MC could be activated and the numerous mediators released, it would be important to develop ways to inhibit stimulation of MC and the release of ANS -relevant mediators. (c) 2023 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:440 / 454
页数:15
相关论文
共 44 条
  • [21] Abnormalities in pH handling by peripheral muscle and potential regulation by the autonomic nervous system in chronic fatigue syndrome
    Jones, D. E. J.
    Hollingsworth, K. G.
    Taylor, R.
    Blamire, A. M.
    Newton, J. L.
    JOURNAL OF INTERNAL MEDICINE, 2010, 267 (04) : 394 - 401
  • [22] Mast Cells in Gut and Brain and Their Potential Role as an Emerging Therapeutic Target for Neural Diseases
    Traina, Giovanna
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2019, 13
  • [23] Chronic fatigue syndrome: What role does the autonomic nervous system play in the pathophysiology of this complex illness?
    Gerrity, TR
    Bates, J
    Bell, DS
    Chrousos, G
    Furst, G
    Hedrick, T
    Hurwitz, B
    Kula, RW
    Levine, SM
    Moore, RC
    Schondorf, R
    NEUROIMMUNOMODULATION, 2002, 10 (03) : 134 - 141
  • [24] Children's altruism following acute stress: The role of autonomic nervous system activity and social support
    Alen, Nicholas V.
    Deer, LillyBelle K.
    Karimi, Mona
    Feyzieva, Elis
    Hastings, Paul D.
    Hostinar, Camelia E.
    DEVELOPMENTAL SCIENCE, 2021, 24 (05)
  • [25] From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system
    Dorninger, Fabian
    Forss-Petter, Sonja
    Berger, Johannes
    FEBS LETTERS, 2017, 591 (18): : 2761 - 2788
  • [26] Central Nervous System Fibroblast-Like Cells in Stroke and Other Neurological Disorders
    Xu, Lingling
    Yao, Yao
    STROKE, 2021, 52 (07) : 2456 - 2464
  • [27] Immune cells: potential carriers or agents for drug delivery to the central nervous system
    Zhang, Shan-Shan
    Li, Ruo-Qi
    Chen, Zhong
    Wang, Xiao-Ying
    Dumont, Aaron S.
    Fan, Xiang
    MILITARY MEDICAL RESEARCH, 2024, 11 (01)
  • [28] Role of microbiota-derived short-chain fatty acids in nervous system disorders
    Mirzaei, Rasoul
    Bouzari, Behnaz
    Hosseini-Fard, Seyed Reza
    Mazaheri, Maryam
    Ahmadyousefi, Yaghoub
    Abdi, Milad
    Jalalifar, Saba
    Karimitabar, Zahra
    Teimoori, Ali
    Keyvani, Hossein
    Zamani, Farhad
    Yousefimashouf, Rasoul
    Karampoor, Sajad
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [29] Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review
    Zhang, Ying
    Guo, Pan
    Ma, Zhe
    Lu, Peng
    Kebebe, Dereje
    Liu, Zhidong
    JOURNAL OF NANOBIOTECHNOLOGY, 2021, 19 (01)
  • [30] The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders
    Costales, Jesse
    Kolevzon, Alexander
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2016, 63 : 207 - 222